June has been a full month of initial public offerings (IPOs), but there are a number of upcoming IPOs still on their way.
IPOs this week are coming from a variety of industries; from finance, to technology, to healthcare. Before the month ends, another four companies will hit the market, initiating some opportunities for investors who like investing in IPOs.
Below is a preview of the four biggest offerings this week. Keep in mind that investing in IPOs may bear a significant amount of risk.
Also Read: Top Five Upcoming IPOs to Watch For 2015
ConforMIS Inc (NASDAQ/CFMS)
ConforMIS Inc (NASDAQ/CFMS) submitted a filing to the Securities and Exchange Commission (SEC) on May 22, 2015 about its IPO. The company has applied to list on NASDAQ under the symbol “CFMS.” ConforMIS is expected to offer over nine million shares between $14.00 and $16.00 per share through the main underwriters Deutsche Bank, J.P. Morgan, and Wells Fargo Securities.
The company operates in medical technology that uses a sophisticated imaging technology platform to develop, manufacture, and sell joint replacement implants that are individually sized. The company has submitted some applications for clearance to the U.S. Food and Drug Administration (FDA). The company generated $48.0 million in revenue in 2014.
LoanCore Realty Trust, Inc. (NYSE/LCRT)
LoanCore Realty Trust, Inc. (NYSE/LCRT) is expected to hit the market next week. The company submitted a filing to the SEC on May 14, 2015 about its IPO. The company has applied to list on the NYSE under the symbol “LCRT.” About 15 million shares at the price of $20.00 are expected to hit the market. The shares will be issued through main underwriters Morgan Stanly, Deutsche Bank, and J.P. Morgan.
LoanCore Realty Trust is a commercial real estate finance company formed to originate, invest in, and manage commercial mortgage loans and other commercial real estate-related assets.
Natera, Inc. (NASDAQ/NTRA)
Natera Inc. (NASDAQ/NTRA) submitted a filing to the SEC on June 1, 2015 to go public. The company will be listed on NASDAQ under the symbol of “NTRA.” The company plans to issue 6.25 million shares priced at $15.00 to $17.00 through main underwriters Morgan Stanly, Cowen Group and Piper Jaffray.
The company operates in rapidly-growing diagnostics with proprietary molecular and bioinformatics technology. The company has launched seven molecular diagnostic tests since 2009, and they plan to launch new products in prenatal testing and oncology in the future.
Teladoc, Inc. (NYSE/TDOC)
Teladoc, Inc. (NYSE/TDOC) submitted a filling to the SEC to go public on May 29, 2015. The company has applied to list on NYSE under the symbol “TDOC.” The tele-health provider is expected to offer over seven million shares between $15.00 and $17.00 per share through the main underwriters Deutsche Bank, J.P. Morgan, and Wells Fargo Securities.
Teladoc is the nation’s first and largest tele-health provider. The Dallas-based company provides new technologies to cut costs by bringing doctors and patients together outside of hospital walls. Customers pay a monthly, per-member fee to access the company’s platform, where hundreds of doctors respond to queries within minutes; sometimes over the phone and sometimes over videoconference. However, the company does not employ full-time doctors and practicing physicians. Rather, they use Teladoc to supplement their practices by fielding inquiries.